Literature DB >> 33420918

Efficient and high-fidelity base editor with expanded PAM compatibility for cytidine dinucleotide.

Zhiquan Liu1, Siyu Chen1, Yingqi Jia1, Huanhuan Shan1, Mao Chen1, Yuning Song1, Liangxue Lai2,3,4,5, Zhanjun Li6.   

Abstract

Cytidine base editor (CBE), which is composed of a cytidine deaminase fused to Cas9 nickase, has been widely used to induce C-to-T conversions in a wide range of organisms. However, the targeting scope of current CBEs is largely restricted to protospacer adjacent motif (PAM) sequences containing G, T, or A bases. In this study, we developed a new base editor termed "nNme2-CBE" with excellent PAM compatibility for cytidine dinucleotide, significantly expanding the genome-targeting scope of CBEs. Using nNme2-CBE, targeted editing efficiencies of 29.0%-55.0% and 17.3%-52.5% were generated in human cells and rabbit embryos, respectively. In contrast to conventional nSp-CBE, the nNme2-CBE is a natural high-fidelity base editing platform with minimal DNA off-targeting detected in vivo. Significantly increased efficiency in GC context and precision were determined by combining nNme2Cas9 with rationally engineered cytidine deaminases. In addition, the Founder rabbits with accurate single-base substitutions at Fgf5 gene loci were successfully generated by using the nNme2-CBE system. These novel nNme2-CBEs with expanded PAM compatibility and high fidelity will expand the base editing toolset for efficient gene modification and therapeutic applications.
© 2021. Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  CRISPR; N4CC PAM; Nme2Cas9; base editor

Mesh:

Substances:

Year:  2021        PMID: 33420918     DOI: 10.1007/s11427-020-1775-2

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  50 in total

1.  A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing.

Authors:  Alireza Edraki; Aamir Mir; Raed Ibraheim; Ildar Gainetdinov; Yeonsoo Yoon; Chun-Qing Song; Yueying Cao; Judith Gallant; Wen Xue; Jaime A Rivera-Pérez; Erik J Sontheimer
Journal:  Mol Cell       Date:  2018-12-20       Impact factor: 17.970

2.  Nursing management of the head injured patient.

Authors:  J Kunkel
Journal:  Crit Care Update       Date:  1981-03

3.  The disrupted balance between hair follicles and sebaceous glands in Hoxc13-ablated rabbits.

Authors:  Jichao Deng; Mao Chen; Zhiquan Liu; Yuning Song; Tingting Sui; Liangxue Lai; Zhanjun Li
Journal:  FASEB J       Date:  2018-08-20       Impact factor: 5.191

4.  CRISPR-Mediated Base Editing Enables Efficient Disruption of Eukaryotic Genes through Induction of STOP Codons.

Authors:  Pierre Billon; Eric E Bryant; Sarah A Joseph; Tarun S Nambiar; Samuel B Hayward; Rodney Rothstein; Alberto Ciccia
Journal:  Mol Cell       Date:  2017-09-07       Impact factor: 17.970

5.  NmeCas9 is an intrinsically high-fidelity genome-editing platform.

Authors:  Nadia Amrani; Xin D Gao; Pengpeng Liu; Alireza Edraki; Aamir Mir; Raed Ibraheim; Ankit Gupta; Kanae E Sasaki; Tong Wu; Paul D Donohoue; Alexander H Settle; Alexandra M Lied; Kyle McGovern; Chris K Fuller; Peter Cameron; Thomas G Fazzio; Lihua Julie Zhu; Scot A Wolfe; Erik J Sontheimer
Journal:  Genome Biol       Date:  2018-12-05       Impact factor: 13.583

6.  Minimal PAM specificity of a highly similar SpCas9 ortholog.

Authors:  Pranam Chatterjee; Noah Jakimo; Joseph M Jacobson
Journal:  Sci Adv       Date:  2018-10-24       Impact factor: 14.136

7.  Versatile and robust genome editing with Streptococcus thermophilus CRISPR1-Cas9.

Authors:  Daniel Agudelo; Sophie Carter; Minja Velimirovic; Alexis Duringer; Jean-François Rivest; Sébastien Levesque; Jeremy Loehr; Mathilde Mouchiroud; Denis Cyr; Paula J Waters; Mathieu Laplante; Sylvain Moineau; Adeline Goulet; Yannick Doyon
Journal:  Genome Res       Date:  2020-01-03       Impact factor: 9.043

8.  Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases.

Authors:  Sangsu Bae; Jeongbin Park; Jin-Soo Kim
Journal:  Bioinformatics       Date:  2014-01-24       Impact factor: 6.937

9.  Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors.

Authors:  Jordan L Doman; Aditya Raguram; Gregory A Newby; David R Liu
Journal:  Nat Biotechnol       Date:  2020-02-10       Impact factor: 54.908

10.  Easy quantitative assessment of genome editing by sequence trace decomposition.

Authors:  Eva K Brinkman; Tao Chen; Mario Amendola; Bas van Steensel
Journal:  Nucleic Acids Res       Date:  2014-10-09       Impact factor: 16.971

View more
  10 in total

1.  Adenine Base Editing In Vivo with a Single Adeno-Associated Virus Vector.

Authors:  Han Zhang; Nathan Bamidele; Pengpeng Liu; Ogooluwa Ojelabi; Xin D Gao; Tomás Rodriguez; Haoyang Cheng; Karen Kelly; Jonathan K Watts; Jun Xie; Guangping Gao; Scot A Wolfe; Wen Xue; Erik J Sontheimer
Journal:  GEN Biotechnol       Date:  2022-06-14

2.  Efficient in vivo base editing via single adeno-associated viruses with size-optimized genomes encoding compact adenine base editors.

Authors:  Jessie R Davis; Xiao Wang; Isaac P Witte; Tony P Huang; Jonathan M Levy; Aditya Raguram; Samagya Banskota; Nabil G Seidah; Kiran Musunuru; David R Liu
Journal:  Nat Biomed Eng       Date:  2022-07-28       Impact factor: 29.234

Review 3.  Therapeutic in vivo delivery of gene editing agents.

Authors:  Aditya Raguram; Samagya Banskota; David R Liu
Journal:  Cell       Date:  2022-07-06       Impact factor: 66.850

4.  High-throughput continuous evolution of compact Cas9 variants targeting single-nucleotide-pyrimidine PAMs.

Authors:  Tony P Huang; Zachary J Heins; Shannon M Miller; Brandon G Wong; Pallavi A Balivada; Tina Wang; Ahmad S Khalil; David R Liu
Journal:  Nat Biotechnol       Date:  2022-09-08       Impact factor: 68.164

5.  Single AAV-mediated CRISPR-Nme2Cas9 efficiently reduces mutant hTTR expression in a transgenic mouse model of transthyretin amyloidosis.

Authors:  Jinkun Wen; Tianqi Cao; Jinni Wu; Yuxi Chen; Shengyao Zhi; Yanming Huang; Peilin Zhen; Guanglan Wu; Lars Aagaard; Jianxin Zhong; Puping Liang; Junjiu Huang
Journal:  Mol Ther       Date:  2021-05-14       Impact factor: 11.454

Review 6.  The Advance of CRISPR-Cas9-Based and NIR/CRISPR-Cas9-Based Imaging System.

Authors:  Huanhuan Qiao; Jieting Wu; Xiaodong Zhang; Jian Luo; Hao Wang; Dong Ming
Journal:  Front Chem       Date:  2021-12-16       Impact factor: 5.221

7.  Highly efficient A-to-G base editing by ABE8.17 in rabbits.

Authors:  Ding Zhao; Yuqiang Qian; Jinze Li; Zhanjun Li; Liangxue Lai
Journal:  Mol Ther Nucleic Acids       Date:  2022-01-28       Impact factor: 8.886

Review 8.  Translational potential of base-editing tools for gene therapy of monogenic diseases.

Authors:  Vasiliy V Reshetnikov; Angelina V Chirinskaite; Julia V Sopova; Roman A Ivanov; Elena I Leonova
Journal:  Front Bioeng Biotechnol       Date:  2022-08-10

Review 9.  The power and the promise of CRISPR/Cas9 genome editing for clinical application with gene therapy.

Authors:  Ning Guo; Ji-Bin Liu; Wen Li; Yu-Shui Ma; Da Fu
Journal:  J Adv Res       Date:  2021-12-04       Impact factor: 12.822

10.  Versatile and efficient in vivo genome editing with compact Streptococcus pasteurianus Cas9.

Authors:  Zhiquan Liu; Siyu Chen; Wanhua Xie; Yuning Song; Jinze Li; Liangxue Lai; Zhanjun Li
Journal:  Mol Ther       Date:  2021-06-24       Impact factor: 11.454

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.